NICE announces roundtable event to ensure implementation of ME/CFS guideline

NICE announced today that it will hold a roundtable in September as the next step in the publication of the ME/CFS guideline. The roundtable will include representatives from patient organisations and charities, relevant professional societies, NHS England and NHS Improvement, NICE and the guideline committee. It aims to, “better understand the issues raised and determine how it can gain support for the guideline to ensure effective implementation.”

We understand the purpose of the roundtable is to move forward by removing the roadblock to implementation and publish the finalised guideline. We will continue to do everything possible to ensure that it is published without delay in its current form in line with NICE’s established procedures.  

The ME community has been badly affected by the unprecedented delay in publishing the new guideline.  This guideline has been worked on for over three years and has used the best available evidence as well as the lived experience of people with ME/CFS. The delay means that the 2007 guideline continues to be referred to by clinicians. In order to ensure that clinicians can implement the best quality of care, we call upon NICE to immediately add a warning to the previous version of the guideline along with an instruction to use the November 2020 draft guideline until the final guideline is published.  
 
The response to our petition calling on NICE to publish the finalised guideline has been overwhelming. Gill Leng, Chief Executive of NICE responded to #MEAction UK’s petition of over 16,500 names saying: ‘NICE has acknowledged that this petition clearly emphasises the strength of feeling on this important issue’.

Facebook
Twitter
WhatsApp
Email

Latest News

Blue square image with starbursts in the corners. the words, submit long covid drug recommendations to recover -tlc! are in the middle of the image, surrounded by thin white lines. the meaction logo is at the top of the image.

Submit Long COVID Drug Recommendations to RECOVER-TLC!

Last month, RECOVER TLC met at NIH headquarters in Bethesda. The goal was to initiate a drug development strategy for Long COVID clinical trials. Now, RECOVER TLC has opened the RECOVER-TLC Intervention Information Request Form, where you can make suggestions about which drugs and other interventions to trial!  Anyone can submit a therapeutic for consideration

Read More »
A classroom of people watching a panel discussion.

The RECOVER-Treating Long COVID (RECOVER TLC) The Path Forward

The RECOVER-Treating Long COVID (RECOVER TLC) Kick-off Meeting was Sept 23-25 in person and over Zoom. I had the privilege of attending over Zoom and Jaime Seltzer, #MEAction’s Scientific Director, represented the needs of the ME community in person and as an invited member of a panel on clinical trial design. There were many speakers

Read More »
Scroll to Top